Log In
Print
BCIQ
Print
Print this Print this
 

Vapendavir (BTA798)

Also known as: BTA-798

  Manage Alerts
Collapse Summary General Information
Company Biota Pharmaceuticals Inc.
DescriptionOral human rhinovirus (HRV) antiviral
Molecular Target HRV capsid
Mechanism of ActionCapsid inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationViral infection
Indication DetailsTreat and prevent human rhinovirus (HRV) infection; Treat human rhinovirus (HRV) infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today